These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16182810

  • 1. Impact of homocysteinemia on long-term renal transplant survival.
    Fonseca I, Martins L, Queirós J, Mendonça D, Dias L, Sarmento AM, Henriques AC, Cabrita A.
    Transplant Proc; 2005; 37(6):2784-8. PubMed ID: 16182810
    [Abstract] [Full Text] [Related]

  • 2. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
    Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, Födinger M, Hörl WH, Sunder-Plassmann G.
    J Am Soc Nephrol; 2005 Jan; 16(1):255-60. PubMed ID: 15563562
    [Abstract] [Full Text] [Related]

  • 3. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM, Gich I, Bonfill X, Solà R, Guirado L, Facundo C, Sainz Z, Puig T, Silva I, Ballarín J.
    Transplant Proc; 2009 Jan; 41(6):2151-5. PubMed ID: 19715859
    [Abstract] [Full Text] [Related]

  • 4. Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients.
    Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A.
    J Am Soc Nephrol; 2006 Jun; 17(6):1746-54. PubMed ID: 16687626
    [Abstract] [Full Text] [Related]

  • 5. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM, McLean D, Kavanagh D, Ward L, Aitken S, Miller GJ, Egan P, Hughes K, Clark L, Carswell K, Morris ST, Northridge DB, Rodger RS, Jardine AG.
    J Nephrol; 2002 Jun; 15(4):380-6. PubMed ID: 12243367
    [Abstract] [Full Text] [Related]

  • 6. Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival.
    Bestard O, Cruzado JM, Torras J, Gil-Vernet S, Serón D, Moreso F, Rama I, Grinyó JM.
    Transplant Proc; 2005 Nov; 37(9):3774-7. PubMed ID: 16386535
    [Abstract] [Full Text] [Related]

  • 7. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients.
    Hagen W, Födinger M, Heinz G, Buchmayer H, Hörl WH, Sunder-Plassmann G.
    Kidney Int Suppl; 2001 Feb; 78():S253-7. PubMed ID: 11169021
    [Abstract] [Full Text] [Related]

  • 8. The first year renal function as a predictor of long-term graft survival after kidney transplantation.
    Helal I, Abderrahim E, Ben Hamida F, Ounissi M, Essine S, Hedri H, Bardi R, Elgorgi Y, El Younsi F, Ben Maiz H, Ben Abdallah T, Kheder A.
    Transplant Proc; 2009 Mar; 41(2):648-50. PubMed ID: 19328945
    [Abstract] [Full Text] [Related]

  • 9. Serum total homocysteine concentration does not predict outcome in renal transplant recipients.
    Dimény E, Hultberg B, Wahlberg J, Fellström B, Arnadottir M.
    Clin Transplant; 1998 Dec; 12(6):563-8. PubMed ID: 9850451
    [Abstract] [Full Text] [Related]

  • 10. The impact of donor spontaneous intracranial haemorrhage vs. other donors on long-term renal graft and patient survival.
    Johnston O, O'Kelly P, Spencer S, Cunningham P, Dorman A, Donohoe J, Walshe JJ, Hickey D, Little DM, Conlon PJ.
    Clin Transplant; 2006 Dec; 20(1):91-5. PubMed ID: 16556161
    [Abstract] [Full Text] [Related]

  • 11. Patient mortality after graft failure reduces kidney transplant patient survival only in the long term: an "intention to treat" analysis.
    Maffei C, Sandrini S, Galanopoulou A, Bossini N, Setti G, Iovinella L, Turina S, Cancarini G.
    Transplant Proc; 2008 Dec; 40(6):1862-4. PubMed ID: 18675071
    [Abstract] [Full Text] [Related]

  • 12. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
    Oterdoom LH, van Ree RM, de Vries AP, Gansevoort RT, Schouten JP, van Son WJ, Homan van der Heide JJ, Navis G, de Jong PE, Gans RO, Bakker SJ.
    Transplantation; 2008 Aug 15; 86(3):391-8. PubMed ID: 18698241
    [Abstract] [Full Text] [Related]

  • 13. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I.
    Transplantation; 2007 Mar 15; 83(5):600-6. PubMed ID: 17353781
    [Abstract] [Full Text] [Related]

  • 14. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES, Nwakanma LU, Patel ND, Yuh DD.
    J Heart Lung Transplant; 2008 Feb 15; 27(2):184-91. PubMed ID: 18267225
    [Abstract] [Full Text] [Related]

  • 15. Impact of donor age on renal allograft function and survival.
    Resende L, Guerra J, Santana A, Mil-Homens C, Abreu F, da Costa AG.
    Transplant Proc; 2009 Apr 15; 41(3):794-6. PubMed ID: 19376354
    [Abstract] [Full Text] [Related]

  • 16. Elevated serum phosphate predicts mortality in renal transplant recipients.
    Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP.
    Transplantation; 2009 Apr 15; 87(7):1040-4. PubMed ID: 19352125
    [Abstract] [Full Text] [Related]

  • 17. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.
    Mitsnefes MM, Khoury PR, McEnery PT.
    J Pediatr; 2003 Jul 15; 143(1):98-103. PubMed ID: 12915832
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP, Patton PR, Meier-Kriesche HU, Li Q, Shenkman B, Fujita S, Reed A, Hemming AW, Kim RD, Howard RJ.
    Clin Transpl; 2005 Jul 15; ():101-9. PubMed ID: 17424728
    [Abstract] [Full Text] [Related]

  • 19. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Mar 15; 38(2):499-501. PubMed ID: 16549159
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar 15; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.